Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2015

Open Access 01-12-2015 | Case report

Transient hypercortisolism and symptomatic hyperthyroidism associated to primary hyperparathyroidism in an elderly patient: case report and literature review

Authors: Chiara Sabbadin, Gabriella Donà, Luciana Bordin, Maurizio Iacobone, Valentina Camozzi, Caterina Mian, Decio Armanini

Published in: BMC Endocrine Disorders | Issue 1/2015

Login to get access

Abstract

Background

Primary hyperparathyroidism (PHPT) is often found on routine blood tests, at a relatively asymptomatic stage. However many studies suggest different systemic effects related to PHPT, which could be enhanced by an abnormal cortisol release due to chronic stress of hyperparathyroidism. Being PHPT frequently found in the 6th to 7th decade of life, a careful and multifaceted approach should be taken.

Case presentation

We report the case of an elderly patient with symptomatic PHPT and incidental pulmonary embolism. He was treated with hydration, zoledronic acid, cinacalcet and high-dose unfractionated heparin. Parathyroid surgery was successfully performed, but patient’s conditions suddenly worsened because of a transient thyrotoxicosis, probably induced by a previous exposure to iodine load and/or thyroid surgical manipulation. A short-term treatment with beta-blockers was introduced for symptomatic relief. The patient also presented a transient hypercortisolism with elevated ACTH, likely due to stress related not only to aging and hospitalization but also to PHPT, resolved only four months after parathyroid surgery.

Conclusion

Chronic hyperparathyroidism has been linked with increased all-cause mortality. A functional chronic hypercortisolism could be established, enhancing PHPT related disorders. Only parathyroid surgery has been demonstrated to cure PHPT and complications related, showing similar outcome between older and younger patients. However, the management of post-operative period should be more careful in fragile patients. In particular, the early diagnosis and treatment of a transient post-operative thyrotoxicosis could improve recovery. Due to the increase in prevalence and the evidence of many related complications even in asymptomatic PHPT, expert opinion-based guidelines for surgical treatment of PHPT should be developed especially for elderly patients.
Literature
1.
go back to reference Pyram R, Mahajan G, Gliwa A: Primary hyperparathyroidism: skeletal and non-skeletal effects, diagnosis and management.Maturitas 2011, 70:246–55. 10.1016/j.maturitas.2011.07.021CrossRefPubMed Pyram R, Mahajan G, Gliwa A: Primary hyperparathyroidism: skeletal and non-skeletal effects, diagnosis and management.Maturitas 2011, 70:246–55. 10.1016/j.maturitas.2011.07.021CrossRefPubMed
2.
go back to reference Conroy S, Moulias S, Wassif WS: Primary hyperparathyroidism in the older person.Age Ageing 2003, 32:571–8. 10.1093/ageing/afg122CrossRefPubMed Conroy S, Moulias S, Wassif WS: Primary hyperparathyroidism in the older person.Age Ageing 2003, 32:571–8. 10.1093/ageing/afg122CrossRefPubMed
3.
go back to reference Smith MR: Zoledronic acid to prevent skeletal complications in cancer: corroborating the evidence.Cancer Treat Rev 2005,31(Suppl 3):19–25.CrossRefPubMed Smith MR: Zoledronic acid to prevent skeletal complications in cancer: corroborating the evidence.Cancer Treat Rev 2005,31(Suppl 3):19–25.CrossRefPubMed
4.
go back to reference Jacobs L, Samson MM, Verhaar HJ, Koek HL: Therapeutic challenges in elderly patients with symptomatic hypercalcaemia caused by primary hyperparathyroidism.Neth J Med 2012, 70:35–8.PubMed Jacobs L, Samson MM, Verhaar HJ, Koek HL: Therapeutic challenges in elderly patients with symptomatic hypercalcaemia caused by primary hyperparathyroidism.Neth J Med 2012, 70:35–8.PubMed
5.
go back to reference Jannasch O, Voigt C, Reschke K, Lippert H, Mroczkowski P: Comparison of outcome between older and younger patients following surgery for primary hyperparathyroidism.Pol Przegl Chir 2013, 85:598–604.PubMed Jannasch O, Voigt C, Reschke K, Lippert H, Mroczkowski P: Comparison of outcome between older and younger patients following surgery for primary hyperparathyroidism.Pol Przegl Chir 2013, 85:598–604.PubMed
6.
go back to reference Rudofsky G Jr, Grafe IA, Metzner C, Leowardi C, Fohr B: Transient post-operative thyrotoxicosis after parathyroidectomy.Med Sci Monit 2009, 15:CS41–3.PubMed Rudofsky G Jr, Grafe IA, Metzner C, Leowardi C, Fohr B: Transient post-operative thyrotoxicosis after parathyroidectomy.Med Sci Monit 2009, 15:CS41–3.PubMed
7.
go back to reference Walfish PG, Caplan D, Rosen B: Postparathyroidectomy transient thyrotoxicosis.J Clin Endocrinol Metab 1992, 75:224–7.PubMed Walfish PG, Caplan D, Rosen B: Postparathyroidectomy transient thyrotoxicosis.J Clin Endocrinol Metab 1992, 75:224–7.PubMed
8.
go back to reference Lindblom P, Valdemarsson S, Westerdahl J, Tennval J, Bergenfelz A: Hyperthyroidism after surgery for primary hyperparathyroidism.Langenbeck’s Arch Surg 1999, 384:568–75. 10.1007/s004230050245CrossRef Lindblom P, Valdemarsson S, Westerdahl J, Tennval J, Bergenfelz A: Hyperthyroidism after surgery for primary hyperparathyroidism.Langenbeck’s Arch Surg 1999, 384:568–75. 10.1007/s004230050245CrossRef
9.
go back to reference Calvi L, Daniels GH: Acute thyrotoxicosis secondary to destructive thyroiditis associated with cardiac catheterization contrast dye.Thyroid 2011, 21:443–9. 10.1089/thy.2010.0300CrossRefPubMed Calvi L, Daniels GH: Acute thyrotoxicosis secondary to destructive thyroiditis associated with cardiac catheterization contrast dye.Thyroid 2011, 21:443–9. 10.1089/thy.2010.0300CrossRefPubMed
10.
go back to reference Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, et al.: Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists.Endocr Pract 2011, 17:456–520. Erratum in: Endocr Pract. 2013;19:384 10.4158/EP.17.3.456CrossRefPubMed Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, et al.: Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists.Endocr Pract 2011, 17:456–520. Erratum in: Endocr Pract. 2013;19:384 10.4158/EP.17.3.456CrossRefPubMed
11.
go back to reference Hintze G, Blombach O, Fink H, Burkhardt U, Kobberling J: Risk of iodine-induced thyrotoxicosis after coronary angiography: an investigation in 788 unselected subjects.Eur J Endocrinol 1999, 140:264–7. 10.1530/eje.0.1400264CrossRefPubMed Hintze G, Blombach O, Fink H, Burkhardt U, Kobberling J: Risk of iodine-induced thyrotoxicosis after coronary angiography: an investigation in 788 unselected subjects.Eur J Endocrinol 1999, 140:264–7. 10.1530/eje.0.1400264CrossRefPubMed
12.
go back to reference Yu N, Donnan PT, Leese GP: A record linkage study outcomes in patients with mild primary hyperparathyroidism: The Parathyroid Epidemiology and Audit Research Study (PEARS).Clin Endocrinol (Oxf) 2011, 75:169–76. 10.1111/j.1365-2265.2010.03958.xCrossRef Yu N, Donnan PT, Leese GP: A record linkage study outcomes in patients with mild primary hyperparathyroidism: The Parathyroid Epidemiology and Audit Research Study (PEARS).Clin Endocrinol (Oxf) 2011, 75:169–76. 10.1111/j.1365-2265.2010.03958.xCrossRef
13.
go back to reference Pilz S, Tomaschitz A, Drechsler C, Ritz E, Boehm BO, Grammer TB, et al.: Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography.Eur Heart J 2010, 31:1591–8. 10.1093/eurheartj/ehq109CrossRefPubMed Pilz S, Tomaschitz A, Drechsler C, Ritz E, Boehm BO, Grammer TB, et al.: Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography.Eur Heart J 2010, 31:1591–8. 10.1093/eurheartj/ehq109CrossRefPubMed
14.
go back to reference Osto E, Fallo F, Pelizzo MR, Maddalozzo A, Sorgato N, Corbetti F, et al.: Coronary microvascular dysfunction induced by primary hyperparathyroidism is restored after parathyroidectomy.Circulation 2012, 126:1031–9. 10.1161/CIRCULATIONAHA.111.081307CrossRefPubMed Osto E, Fallo F, Pelizzo MR, Maddalozzo A, Sorgato N, Corbetti F, et al.: Coronary microvascular dysfunction induced by primary hyperparathyroidism is restored after parathyroidectomy.Circulation 2012, 126:1031–9. 10.1161/CIRCULATIONAHA.111.081307CrossRefPubMed
15.
go back to reference Sabbadin C, Cavedon E, Zanon M, Iacobone M, Armanini D: Resolution of hypertension and secondary aldosteronism after surgical treatment of primary hyperaldosteronism.J Endocrinol Invest 2013, 36:665–6.PubMed Sabbadin C, Cavedon E, Zanon M, Iacobone M, Armanini D: Resolution of hypertension and secondary aldosteronism after surgical treatment of primary hyperaldosteronism.J Endocrinol Invest 2013, 36:665–6.PubMed
16.
go back to reference Gianotti L, Tassone F, Pia A, Bovio S, Reimondo G, Visconti G, et al.: May an altered hypotalamo-pituitary-adrenal axis contribute to cortical bone damage in primary hyperparathyroidism?Calcif Tissue Int 2009, 84:425–9. 10.1007/s00223-009-9245-7CrossRefPubMed Gianotti L, Tassone F, Pia A, Bovio S, Reimondo G, Visconti G, et al.: May an altered hypotalamo-pituitary-adrenal axis contribute to cortical bone damage in primary hyperparathyroidism?Calcif Tissue Int 2009, 84:425–9. 10.1007/s00223-009-9245-7CrossRefPubMed
17.
go back to reference Mazzocchi G, Aragona F, Malendowicz LK, Nussdorfer GG: PTH and PTH-related peptide enhance steroid secretion from human adrenocortical cells.Am J Physiol Endocrinol Metab 2001, 280:E209–13.PubMed Mazzocchi G, Aragona F, Malendowicz LK, Nussdorfer GG: PTH and PTH-related peptide enhance steroid secretion from human adrenocortical cells.Am J Physiol Endocrinol Metab 2001, 280:E209–13.PubMed
18.
go back to reference Fuleihan GE-H, Brown EM, Gleason R, Scott J, Adler GK: Calcium modulation of adrenocorticotropin levels in women – a clinical research study.J Clin Endocrinol Metab 1996, 81:932–6.PubMed Fuleihan GE-H, Brown EM, Gleason R, Scott J, Adler GK: Calcium modulation of adrenocorticotropin levels in women – a clinical research study.J Clin Endocrinol Metab 1996, 81:932–6.PubMed
19.
go back to reference Rajput R, Bhansali A, Bhadada SK, Behera A, Mittal BR, Sialy R, et al.: A pilot study on hypothalamo-pituitary-adrenocortical axis in primary hyperparathyroidism.Indian J Med Res 2009, 130:418–22.PubMed Rajput R, Bhansali A, Bhadada SK, Behera A, Mittal BR, Sialy R, et al.: A pilot study on hypothalamo-pituitary-adrenocortical axis in primary hyperparathyroidism.Indian J Med Res 2009, 130:418–22.PubMed
20.
go back to reference Armanini D: Corticosteroid receptors in lymphocytes: a possible marker of brain involution?J Steroid Biochem Mol Biol 1994, 49:429–34. 10.1016/0960-0760(94)90289-5CrossRefPubMed Armanini D: Corticosteroid receptors in lymphocytes: a possible marker of brain involution?J Steroid Biochem Mol Biol 1994, 49:429–34. 10.1016/0960-0760(94)90289-5CrossRefPubMed
21.
go back to reference Aguilera G: HPA axis responsiveness to stress: implications for healthy aging.Exp Gerontol 2011, 46:90–5. 10.1016/j.exger.2010.08.023CrossRefPubMed Aguilera G: HPA axis responsiveness to stress: implications for healthy aging.Exp Gerontol 2011, 46:90–5. 10.1016/j.exger.2010.08.023CrossRefPubMed
22.
go back to reference Tirabassi G, Boscaro M, Arnaldi G: Harmful effects of functional hypercortisolism: a working hypothesis.Endocrine 2014, 46:370–86. 10.1007/s12020-013-0112-yCrossRefPubMed Tirabassi G, Boscaro M, Arnaldi G: Harmful effects of functional hypercortisolism: a working hypothesis.Endocrine 2014, 46:370–86. 10.1007/s12020-013-0112-yCrossRefPubMed
Metadata
Title
Transient hypercortisolism and symptomatic hyperthyroidism associated to primary hyperparathyroidism in an elderly patient: case report and literature review
Authors
Chiara Sabbadin
Gabriella Donà
Luciana Bordin
Maurizio Iacobone
Valentina Camozzi
Caterina Mian
Decio Armanini
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2015
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/1472-6823-15-4

Other articles of this Issue 1/2015

BMC Endocrine Disorders 1/2015 Go to the issue